NEWRON PHARMA (Switzerland) Today

Equity ratings for NEWRON PHARMA N are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 11th of August 2019 and ending today, the 31st of July 2021. Click here to learn more.
NEWRON PHARMA N cannot be verified against its exchange. Apparently, NEWRON PHARMA is not available for investing at the moment. Please verify the symbol is currently traded on Switzerland Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

NEWRON PHARMA Stock Profile

Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system in Italy and internationally. The company was founded in 1998 and is headquartered in Bresso, Italy. NEWRON PHARMA operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 24 people.. The public information regarding NEWRON PHARMA N's current market price is not available at this time.
NEWRON PHARMA N is not yet fully synchronised with the market data
NEWRON PHARMA N has some characteristics of a very speculative penny stock
NEWRON PHARMA N has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 4.37 M. Net Loss for the year was (16.8 M) with profit before overhead, payroll, taxes, and interest of 4.03 M.
NEWRON PHARMA N has accumulated about 58.99 M in cash with (19.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.31.
Legal NameNEWRON PHARMA N
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of NEWRON PHARMA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
NEWRON PHARMA N (NWRN) is traded on Switzerland Exchange in Switzerland and employs 24 people. The company currently falls under 'Small-Cap' category with current market capitalization of 107.79 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NEWRON PHARMA's market, we take the total number of its shares issued and multiply it by NEWRON PHARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. NEWRON PHARMA N operates under Healthcare sector and is part of Biotechnology industry. The entity has 17.85 M outstanding shares. NEWRON PHARMA N has accumulated about 58.99 M in cash with (19.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.31.
Check NEWRON PHARMA Probability Of Bankruptcy

NEWRON Stock Against Markets

Picking the right benchmark for NEWRON PHARMA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in NEWRON PHARMA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for NEWRON PHARMA is critical whether you are bullish or bearish towards NEWRON PHARMA N at a given time.
NEWRON PHARMA N cannot be verified against its exchange. Apparently, NEWRON PHARMA is not available for investing at the moment. Please verify the symbol is currently traded on Switzerland Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NEWRON PHARMA stock to make a market-neutral strategy. Peer analysis of NEWRON PHARMA could also be used in its relative valuation, which is a method of valuing NEWRON PHARMA by comparing valuation metrics with similar companies.
Check out Stocks Correlation. Note that the NEWRON PHARMA N information on this page should be used as a complementary analysis to other NEWRON PHARMA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Directory module to find actively traded corporate debentures issued by US companies.

Other Tools for NEWRON Stock

When running NEWRON PHARMA N price analysis, check to measure NEWRON PHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NEWRON PHARMA is operating at the current time. Most of NEWRON PHARMA's value examination focuses on studying past and present price action to predict the probability of NEWRON PHARMA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move NEWRON PHARMA's price. Additionally, you may evaluate how the addition of NEWRON PHARMA to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go